|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.090 USD | +2.87% |
|
-0.65% | -8.94% |
| 05-13 | Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-12 | Harvard Bioscience, Inc., Q1 2026 Earnings Call, May 12, 2026 |
| Market Cap | 26.7M 23.46M 21.9M 20.1M 37.62M 2.56B 38.55M 260M 102M 1.27B 100M 98.07M 4.37B | P/E 2026 * |
-3.02x | P/E 2027 * | -13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 26.7M 23.46M 21.9M 20.1M 37.62M 2.56B 38.55M 260M 102M 1.27B 100M 98.07M 4.37B | EV / Sales 2026 * |
0.3x | EV / Sales 2027 * | 0.28x |
| Free-Float |
90.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harvard Bioscience, Inc.
| 1 day | +2.87% | ||
| 1 week | -0.65% | ||
| Current month | -0.98% | ||
| 1 month | -0.57% | ||
| 3 months | -0.65% | ||
| 6 months | +13.49% | ||
| Current year | -8.94% |
| 1 week | 5.91 |  | 6.24 |
| 1 month | 5.9 | | 6.72 |
| Current year | 4 | | 7.5 |
| 1 year | 3.76 | | 9.4 |
| 3 years | 2.81 | | 55.6 |
| 5 years | 2.81 | | 87.5 |
| 10 years | 2.81 | | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Duke
CEO | Chief Executive Officer | 55 | 28/07/2025 |
Mark Frost
DFI | Director of Finance/CFO | 63 | 12/05/2025 |
Diane Houston
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Katherine Eade
BRD | Director/Board Member | 52 | 24/10/2017 |
John Duke
BRD | Director/Board Member | 55 | 02/06/2025 |
Robert Gagnon
BRD | Director/Board Member | 52 | 16/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/6/26 | Free | Director | 16,556 | 0.3671% | ||
| 9/6/26 | Free | Director | 16,556 | 0.3671% | ||
| 9/6/26 | Free | Director | 16,556 | 0.3671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.87% | -0.65% | +21.82% | -86.90% | 26.97M | |
| -0.51% | +8.71% | +18.70% | +4.31% | 214B | |
| -0.56% | +10.53% | -4.28% | -22.37% | 140B | |
| -2.04% | +4.00% | -28.69% | +9.22% | 128B | |
| +0.58% | +6.63% | -56.96% | -11.63% | 68.46B | |
| +2.44% | +1.05% | +5.95% | +3.88% | 48.18B | |
| +4.51% | +8.59% | -22.65% | -28.93% | 45.56B | |
| -0.31% | +4.88% | +16.80% | +14.95% | 39.69B | |
| -1.03% | +2.45% | +25.30% | +37.54% | 37.69B | |
| +2.46% | +10.46% | -23.27% | -4.16% | 30.14B | |
| Average | +0.83% | +3.87% | -4.73% | -8.41% | 75.17B | |
| Weighted average by Cap. | -0.09% | +5.29% | -5.30% | -1.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 88.6M 77.85M 72.67M 66.69M 125M 8.49B 128M 862M 337M 4.2B 333M 325M 14.52B | 94.2M 82.77M 77.26M 70.91M 133M 9.02B 136M 916M 358M 4.46B 354M 346M 15.43B |
| Net income | -9.05M -7.95M -7.42M -6.81M -12.75M -867M -13.07M -88.02M -34.42M -429M -33.98M -33.24M -1.48B | -2.05M -1.8M -1.68M -1.54M -2.89M -196M -2.96M -19.94M -7.8M -97.17M -7.7M -7.53M -336M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | US$6.090 | +2.87% | 2,557 |
| 28/07/26 | US$5.920 | -1.17% | 8,997 |
| 27/07/26 | US$5.990 | -0.17% | 7,883 |
| 24/07/26 | US$6.000 | -3.07% | 6,032 |
| 23/07/26 | US$6.190 | +0.98% | 5,421 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HBIO Stock
Select your edition
All financial news and data tailored to specific country editions
